ABT monthly performance report
Explore ABT's monthly returns, drawdown, and seasonality trends — updated every month.
ABT monthly report
—
Key takeaways
- Abbott Laboratories (ABT) closed September 2026 at $102.61, down 7.02% for the month and −23.75% over the trailing 12 months.
- Year-to-date, ABT is −18.10%, underperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading −3.00% versus its 200-day moving average ($105.78), a cautious technical signal.
- Over the past three years, ABT has underperformed the S&P 500 by −70.10%, with a relative strength index reading of 59.2.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Abbott Laboratories ended September 2026 at $102.61, posting a monthly return of −7.02%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −6.32%.
The current quarter stands at +13.08% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −3.00% versus the 200-day moving average ($105.78).
Year-to-date, ABT is −18.10% against SPY +11.70%, a gap of −29.80%. The stock is currently −25.37% below its 52-week high, with maximum 3-year drawdown at −41.12%.
| Period | ABT | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.37% | −0.12% | +0.49% |
| 1 Week | +0.65% | −0.34% | +0.99% |
| 1 Month | −7.02% | −0.70% | −6.32% |
| 3 Months | +13.23% | +2.80% | +10.43% |
| 6 Months | −5.02% | +13.85% | −18.87% |
| YTD | −18.10% | +11.70% | −29.80% |
| 12 Months | −23.75% | +15.01% | −38.76% |
| 3 Years | +1.59% | +71.69% | −70.10% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +16.49% |
| #2 | Jan 2025 | +13.10% |
| #3 | Nov 2023 | +10.30% |
| #4 | Feb 2025 | +7.88% |
| #5 | Aug 2024 | +6.92% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | −12.76% |
| #2 | Mar 2026 | −11.76% |
| #3 | Apr 2026 | −11.57% |
| #4 | Oct 2025 | −7.70% |
| #5 | Aug 2023 | −7.57% |
| Quarter | Return |
|---|---|
| Q2 2025 | +2.53% |
| Q3 2025 | −1.52% |
| Q4 2025 | −6.46% |
| Q1 2026 | −18.05% |
| Q2 2026 | −11.62% |
| Q3 2026 (QTD) | +13.08% |
| Year | Return |
|---|---|
| 2023 | +0.26% |
| 2024 | +2.76% |
| 2025 | +10.77% |
| 2026 | −18.10% |
| Metric | Value |
|---|---|
| 52-Week High | $137.49 (2025-09-22) |
| 52-Week Low | $81.97 (2026-05-11) |
| Current Price | $102.61 |
| 200-Day Moving Average | $105.78 |
| Price vs 200DMA | −3.00% |
| 3-Year Maximum Drawdown | −41.12% (2026-05-11) |
| Current Drawdown from 52W High | −25.37% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 59.2 |
| 3-Year Excess Return vs S&P 500 | −70.10% |
| RS Peak | 111 (Apr 2025) |
| RS Trough | 49.1 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ABT's return for this report period?
ABT returned −7.02% in the latest monthly window ending 2026-09-18.
Has ABT outperformed SPY year to date?
YTD ABT: −18.10% vs SPY: +11.70%.
What is ABT's 12-month return?
−23.75% over the trailing 12 months.
Is ABT above or below its 200-day moving average?
Price is −3.00% versus 200DMA ($105.78).
What is the maximum drawdown in the 3-year window?
−41.12% on 2026-05-11.